Up-regulation of inhibitors of protein phosphatase-2A in Alzheimer's disease

American Journal of Pathology

Volumn 166, Issue 6, 2005, Pages 1761-1771

  Tanimukai, Hitoshi ^a   Grundke Iqbal, Inge ^a   Iqbal, Khalid ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY RNA; MESSENGER RNA; MONOCLONAL ANTIBODY; PHOSPHOPROTEIN PHOSPHATASE 2A; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; POLYCLONAL ANTIBODY; RECOMBINANT PROTEIN; SYNTHETIC PEPTIDE;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENTORHINAL CORTEX; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MASS SPECTROMETRY; NEUROFIBRILLARY TANGLE; NEUROLOGIC DISEASE; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TEMPORAL CORTEX; WESTERN BLOTTING;

EID: 19544362550     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)62486-8     Document Type: Article

References (50)

1. Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI: Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 1986, 83:4913-4917
2. Iqbal K, Grundke-Iqbal I, Smith AJ, George L, Tung YC, Zaidi T: Identification and localization of tau peptide to paired helical filaments of Alzheimer disease. Proc Natl Acad Sci USA 1989, 86:5646-5650
3. Lee VM, Balin BJ, Otvos Jr L, Trojanowski JQ: A68: a major subunit of paired helical filaments and derivatized forms of normal tau. Science 1991, 251:675-678
4. Weingarten MD, Lockwood AH, Hwo SY, Kirschner MW: A protein factor essential for microtubule assembly. Proc Natl Acad Sci USA 1975, 72:1858-1862
5. Alonso A del C, Zaidi T, Grundke-Iqbal I, Iqbal K: Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease. Proc Natl Acad Sci USA 1994, 91:5562-5566
6. Alonso A del C, Grundke-Iqbal I, Iqbal K: Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. Nat Med 1996, 2:783-787
7. Alonso A del C, Grundke-Iqbal I, Barra HS, Iqbal K: Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of MAP1 and MAP2 and the disassembly of microtubules by the abnormal tau. Proc Natl Acad Sci USA 1997, 94:298-303
8. Gong CX, Singh TJ, Grundke-Iqbal I, Iqbal K: Phosphoprotein phosphatase activities in Alzheimer disease brain. J Neurochem 1993, 61:921-927
9. Gong CX, Shaikh S, Wang JZ, Zadi T, Grundke-Iqbal I, Iqbal K: Phosphatase activity toward abnormally phosphorylated tau: decrease in Alzheimer disease brain. J Neurochem 1995, 65:732-738
10. Gong CX, Lidsky T, Wegiel J, Zuck L, Grundke-Iqbal I, Iqbal K: Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer's disease. J Biol Chem 2000, 275:5534-5544
11. Sun L, Liu SY, Zhou XW, Wang XC, Liu R, Wang Q, Wang JZ: Inhibition of protein phosphatases 2A and protein phosphatases 1 induced tau phosphorylation and impairment of spatial memory retention in rats. Neuroscience 2003, 118:1175-1182
12. Vogelsberg-Ragaglia V, Schuck T, Trojanowski JQ, Lee VM: PP2A mRNA expression is quantitatively decreased in Alzheimer's disease hippocampus. Exp Neurol 2001, 168:402-412
13. Loring JF, Wen X, Lee JM, Seilhamer J, Somogyi R: A gene expression profile of Alzheimer's disease. DNA Cell Biol 2001, 20:683-695
14. Blalock EM, Geddes JW, Chen KC, Porter NM, Markesbery WR, Landfield PW: Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc Natl Acad Sci USA 2004, 101:2173-2178
15. Sontag E, Luangpirom A, Hladik C, Mudrak I, Ogris E, Speciale S, White III CL: Altered expression levels of the protein phosphatase 2A ABalphaC enzyme are associated with Alzheimer disease pathology. J Neuropathol Exp Neurol 2004, 63:287-301
16. Sontag E, Hladik C, Montgomery L, Luangpirom A, Mudrak I, Ogris E, White III CL: Downregulation of protein phosphatase 2A carboxyl methylation and methyltransferase may contribute to Alzheimer disease pathogenesis. J Neuropathol Exp Neurol 2004, 63:1080-1091
17. Li M, Guo H, Damuni Z: Purification and characterization of two potent heat-stable protein inhibitors of protein phosphatase 2A from bovine kidney. Biochemistry 1995, 34:1988-1996
18. PP2A, a novel potent heat-stable inhibitor protein of protein phosphatase 2A. Biochemistry 1996, 35:6998-7002
19. Li M, Makkinje A, Damuni Z: The myeloid leukemia-associated protein SET is a potent inhibitor of protein phosphatase 2A. J Biol Chem 1996, 271:11059-11062
20. Vaesen M, Barnikol-Watanabe S, Gotz H, Awni LA, Cole T, Zimmermann B, Kratzin HD, Hilschmann N: Purification and characterization of two putative HLA class II associated proteins: PHAPI and PHAPII. Biol Chem Hoppe Seyler 1994, 357:113-126
21. Matsuoka K, Taoka M, Satozawa N, Nakayama H, Ichimura T, Takahashi N, Yamakuni T, Song SY, Isobe T: A nuclear factor containing the leucine-rich repeats expressed in murine cerebellar neurons. Proc Natl Acad Sci USA 1994, 91:9670-9674
22. Chen TH, Brody JR, Romantsev FE, Yu JG, Kayler AE, Voneiff E, Kuhajda FP, Pasternack GR: Structure of pp32, an acidic nuclear protein which inhibits oncogene-induced formation of transformed foci. Mol Biol Cell 1996, 7:2045-2056
23. Ulitzur N, Rancano C, Pfeffer SR: Biochemical characterization of mapmodulin, a protein that binds microtubule-associated proteins. J Biol Chem 1997, 272:30577-30582
24. von Linden M, van Baal S, Wiegant J, Raap A, Hagemeijer A, Grosveld G: Can, a putative oncogene associated with myeloid leukemogenesis, may be activated by fusion of its 3′ half to different genes: characterization of the set gene. Mol Cell Biol 1992, 12:3346-3355
25. Nagata K, Kawase H, Handa H, Yano K, Yamasaki M, Ishimi Y, Okuda A, Kikuchi A, Matsumoto K: Replication factor encoded by a putative oncogene, set, associated with myeloid leukemogenesis. Proc Natl Acad Sci USA 1995, 92:4279-4283
26. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlar EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944
27. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L: The Consortium to Establish A Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991, 41:479-486
28. Tanimukai H, Grundke-Iqbal I, Iqbal K: Inhibitors of protein phosphatases-2A: topology and subcellular localization. Mol Brain Res 2004, 126:146-156
29. Tsujio I, Zaidi T, Xu J, Kotula L, Grundke-Iqbal I, Iqbal K: Inhibitors of protein phosphatase-2A from human brain: structures, immunocytological localization and activities towards dephosphorylation of the Alzheimer type hyperphosphorylated tau. FEBS Lett (in press)
30. Greenberg SG, Davies P, Schein JD, Binder LI: Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau. J Biol Chem 1992, 267:564-569
31. Otvos Jr L, Feiner L, Lang E, Szendrei GI, Goedert M, Lee VM: Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404. J Neurosci Res 1994, 39:669-673
32. Hasegawa M, Watanabe A, Takio K, Suzuki M, Arai T, Titani K, Ihara Y: Characterization of two distinct monoclonal antibodies to paired helical filaments: further evidence for fetal-type phosphorylation of the tau in paired helical filaments. J Neurochem 1993, 60:2068-2077
33. 262 in fetal tau, adult tau and paired helical filament tau. J Biol Chem 1995, 270:18917-18922
34. Malek SN, Katumuluwa AI, Pasternack GR: Identification and preliminary characterization of two related proliferation-associated nuclear phosphoproteins. J Biol Chem 1990, 265:13400-13409
35. Adachi Y, Pavlakis GN, Copeland TD: Identification and characterization of SET, a nuclear phosphoprotein encoded by the translocation break point in acute undifferentiated leukemia. J Biol Chem 1994, 269:2258-2262
36. Nagata K, Saito S, Okuwaki M, Kawase H, Furuya A, Kusano A, Hanai N, Okuda A, Kikuchi A: Cellular localization and expression of template-activating factor I in different cell types. Exp Cell Res 1998, 240:274-281
37. Iqbal K, Alonso A del C, El-Akkad E, Gong CX, Hague N, Khatoon S, Tanimukai H, Tsujio I, Grundke-Iqbal I: Pivotal role of neurofibrillary degeneration in Alzheimer disease and therapeutic targets. Molecular Neurobiology of Alzheimer Disease and Related Disorders. Edited by Takeda M, Tanaka T, Cacabelos R. Basel, Karger, 2004, pp 42-51
38. Braak H, Griffing K, Braak E: Neuroanatomy of Alzheimer's disease. Alzheimer's Res 1997, 3:235-247
39. Brennan CM, Gallouzi IE, Steitz JA: Protein ligands to HuR modulate its interaction with target mRNAs in vivo. J Cell Biol 2000, 151:1-14
40. Beresford PJ, Kam CM, Powers JC, Lieberman J: Recombinant human granzyme A binds to two putative HLA-associated proteins and cleaves one of them. Proc Natl Acad Sci USA 1997, 94:9285-9290
41. Beresford PJ, Zhang D, Oh DY, Fan Z, Greer EL, Russo ML, Jaju M, Lieberman J: Granzyme A activates an endoplasmic reticulum-associated caspase-independent nuclease to induce single-stranded DNA nicks. J Biol Chem 2001, 276:43285-43293
42. Saito S, Miyaji-Yamaguchi M, Shimoyama T, Nagata K: Functional domains of template-activating factor-I as a protein phosphatases 2A inhibitor. Biochem Biophys Res Commun 1999, 259:471-475
43. Pei JJ, Sersen E, Iqbal K, Grundke-Iqbal I: Expression of protein phosphatases (PP-1, PP2A, PP-2B and PTP-1B) and protein kinases (MAP kinase and P34cdc2) in the hippocampus of patients with Alzheimer disease and normal aged individuals. Brain Res 1994, 655:70-76
44. Janssens V, Goris J: Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signaling. Biochem J 2001, 353:417-439
45. Yu LG, Packman LC, Weldon M, Hamlett J, Rhodes JM: Protein phosphatase 2A, a negative regulator of the ERK signaling pathway, is activated by tyrosine phosphorylation of putative HLA class II-associated protein I (PHAPI)/pp32 in response to the antiproliferative lectin, jacalin. J Biol Chem 2004, 279:41377-41383
46. Bennecib M, Gong CX, Grundke-Iqbal I, Iqbal K: Inhibition of PP-2A upregulates CaMKII in rat forebrain and induces hyperphosphorylation of tau at Ser 262/356. FEBS Lett 2001, 490:15-22
47. Li L, Sengupta A, Haque N, Grundke-Iqbal I, Iqbal K: Memantine inhibits and reverses the Alzheimer type abnormal hyperphosphorylation of tau and associated neurodegeneration. FEBS Lett 2004, 566:261-269
48. An WL, Cowburn RF, Li L, Braak H, Alafuzoff I, Iqbal K, Grundke-Iqbal I, Winblad B, Pei JJ: Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease. Am J Pathol 2003, 163:591-607
49. Kins S, Kurosinski P, Nitsch RM, Gotz J: Activation of the ERK and JNK signaling pathways caused by neuron-specific inhibition of PP-2A in transgenic mice. Am J Pathol 2003, 163:833-843
50. Pei JJ, Gong CX, An WL, Winblad B, Cowburn RF, Grundke-Iqbal I, Iqbal K: Okadaic-acid-induced inhibition of protein phosphatase 2A produces activation of mitogen-activated protein kinases ERK1/2, MEK1/2, and p70 S6, similar to that in Alzheimer's disease. Am J Pathol 2003, 163:845-858